ILCA23 – Call For Abstracts Now Open!
Present your research at #ILCA23
We are pleased to announce that the call for abstracts for the 17th ILCA Annual Conference, taking place this 7-9 September in Amsterdam, The Netherlands, is now open! Submit your latest research to speak at the world’s leading liver cancer meeting.
Click here to submit your abstract!
Share your expertise!
The ILCA AC23 conference is the largest gathering of liver cancer experts in the world and also a platform for sharing your expertise with the global liver cancer community.
If you are interested in submitting an abstract for the ILCA 2023 scientific programme, we would love to have your input. Abstracts should address all aspects of liver cancer with a clear emphasis on one of the below categories:
– Molecular Pathogenesis, Cell Biology and Translational Research
– Epidemiology, Staging and Prognosis
– Surveillance and diagnosis
– Therapy & Miscellaneous & Clinical Trials in progress
The global liver cancer community is growing and evolving
We want to make sure that our community gets the most up-to-date information on the latest advances in research, treatment options and patient support. Therefore, entries will be carefully reviewed to ensure we deliver the best educational experience to our attendees.
Submission guidelines
Join us for ILCA’s first webinar of 2023!
Benefits and risks of systemic therapy for patients with HCC awaiting liver transplantation
Tuesday, February 21, 2023
3:00 PM – 4:00 PM CET
The webinar will cover the available data regarding the use of immunotherapy for HCC in the setting of liver transplantation, including any modification in perioperative management.
Chairs:
Julie Heimbach | Director, William Von Liebig Center for Transplantation, Professor of Surgery, Mayo Clinic College of Medicine, US
Olivier Rosmoduc | Hepatologist and liver oncologist in Hepato-Biliary Centre at Paul Brousse Hospital – Villejuif, France
Meet the speakers:
Myron Schwartz | Clinical Director of the Mount Sinai Liver Cancer Program, New York, US
Ahmed Kaseb | Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Anjana Pillai | Medical Director of the multidisciplinary liver tumor program at UChicago Medicine, US
Registration will open shortly, stay tuned!